Arcadia Biosciences Inc (RKDA) Stock Analysis

Arcadia Biosciences Inc (RKDA) is a publicly traded company in the CONSUMER DEFENSIVE sector. It trades at $1.01, carries a market capitalization of $1.88M. This page summarizes the public market data, fundamentals, and frequently asked questions for RKDA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: CONSUMER DEFENSIVE - PACKAGED FOODS

Exchange: NASDAQ

Key Metrics

• Price: $1.01
• Market Cap: $1.88M
• EPS: $-5.72
• 52-Week High: $5.72
• 52-Week Low: $0.80

Market Sentiment

Arcadia Biosciences Inc currently has a Neutral sentiment score of 0.09.

About Arcadia Biosciences Inc

Arcadia Biosciences, Inc. (Ticker: RKDA) is a pioneering biotechnology company headquartered in Davis, California, dedicated to enhancing sustainable agriculture through the innovation of crop productivity traits in high-value crops including hemp, wheat, and soybeans. By harnessing cutting-edge agricultural technologies, Arcadia focuses on improving yields, increasing resilience, and ensuring food security, all while adhering to environmentally sustainable practices. As demand for bioenginee...

GNG Research Analysis

GNG Research scores Arcadia Biosciences Inc (RKDA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RKDA.

Frequently Asked Questions

Does RKDA pay dividends?

Arcadia Biosciences Inc (RKDA) does not currently pay a regular dividend.

What is RKDA's market cap?

Arcadia Biosciences Inc (RKDA) has a market capitalization of $1.88M with a current stock price of $1.01.